Regentis Biomaterials LTD. reports a Return on Equity (ROE) of -287.69%.

What is RGNT's dividend yield?

Regentis Biomaterials LTD. offers a dividend yield of 0.00%.

What is RGNT's Quality Score?

Our AI rates RGNT's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy RGNT?

Our AI Timing Score for RGNT is 28 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does RGNT belong to?

Regentis Biomaterials LTD. is classified under the Healthcare >> Medical Instruments & Supplies sector on the NYSE exchange

Regentis Biomaterials LTD. (RGNT) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2025-12-31)

RGNT AI Analysis Summary

Our AI summary for RGNT: Regentis Biomaterials LTD. (NYSE), Healthcare >> Medical Instruments & Supplies sector. The stock currently trades at a P/E of 0.00, ROE of -287.69%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 28/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

RGNT

Regentis Biomaterials LTD.

US:NYSE STOCK Healthcare >> Medical Instruments & Supplies

USD 1.74

-0.06 (-3.33%) Day Change

Watchlist Portfolio Compare Chart

0.61

D/E

-287.7%

ROE

-179.2%

ROA

0.00%

Div Yield

Data partially updated

REGENTIS BIOMATERIALS LTD.
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 1.74 Price -0.06 (-3.33%) Day Change	NEWS SCORE: N/A

RGNT, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...

No price data to display chart for the last 3-months of this stock

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

44%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	1.74
PBV / Sector	1.90 / 3.37
Earning Per Share	-2.64

PE / Sector	N/A / 44.25
PEG or PE/Growth / Sector	N/A / -1.35
Average 1M Daily Value	0.15 M GREAT
Average 1W Daily Value	0.15 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 82.17
NPM Average (%) / Sector	N/A / 28.91
NPM Change Average (%) / Sector	N/A / 208.28
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-179.15 / 7.70
ROA Average (%) / Sector	-103.82 / -22.17
ROA Change Average (%) / Sector	318.43 / 105.15 GREAT
ROE (%) / Sector	-287.69 / 10.10
ROE Average (%) / Sector	-71.73 / 392.40
ROE Change Average (%) / Sector	764.86 / 109.80 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.99
Dividend Average (%) / Sector	N/A / 1.43
Dividend Change Average (%) / Sector	N/A / 11.29

Registration Details

Analyze Date	2026-08-01 08:00:24
Symbol	RGNT
Name	REGENTIS BIOMATERIALS LTD.
Sector	Healthcare >> Medical Instruments & Supplies
Market	NYSE
Listed Shares	7.02 M
Par Value	N/A
Calculated From	YearEnd
Sign	N/A
Market Cap (M.USD) / Sector Average	9.01 / 16,159.14

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 60, Medinat Hayehudim, Herzliya, Israel, 4676652

Phone: 972 9 960 1917

Website: https://www.regentis.co.il

Employees: -

Sector: Healthcare >> Medical Instruments & Supplies

Description: Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.